| | | 58271 | | 28.05.2009 | | Novartis Pharma Schweiz AG | | | | | | | 27.05.2019 | | | | | | 08.08. | | 08.12.2016 | | 08.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Optaflu | Injektionssuspension | Injection suspension () + ( 0 ) | J07BB02 | | | 02 | Optaflu | Injektionssuspension | Injection suspension ( 15 µg, 15 µg, 15 µg) | J07BB02 | | | 03 | Optaflu | Injektionssuspension | Injection suspension ( 15 µg, 15 µg, 15 µg) | J07BB02 | |
|
|
